abacavir
12 May 2018. Related: ARVs and PrEP, Nukes
Nukes
Atripla / TLE (efavirenz + tenofovir DF + emtricitabine/lamivudine)
2 February 2025. Related: ARVs and PrEP, Fixed dose combinations, NNRTIs, Nukes
Generic versions of Atripla (pictured) will look different. It is sometimes called TLE or AF2B.
Generic versions include Atenef, Atreslawin, Atroiza, Citenvir, Heftenam, Odimune, Rizene, Teevir, Trenvir, Tribuss, Triolar, Trivenz, Truno, Trustiva, Viraday and Vonavir.
Full details about Atripla / TLE (efavirenz + tenofovir DF + emtricitabine/lamivudine)
AZT (zidovudine)
1 April 2013. Related: ARVs and PrEP, Nukes
Biktarvy: bictegravir/emtricitabine/TAF
30 August 2024. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes
Biktarvy is a pink/grey film-coated tablet (15 mm x 8 mm) with “GSI” on one side and “9883” on the other.
Combivir (AZT + 3TC)
26 August 2012. Related: ARVs and PrEP, Nukes
d4T (stavudine)
4 January 2016. Related: ARVs and PrEP, Nukes
No longer recommended in the UK.
ddI (didanosine)
4 January 2016. Related: ARVs and PrEP, Nukes
No longer recommended in the UK.
Descovy (TAF + emtricitabine)
12 May 2018. Related: ARVs and PrEP, Nukes, PrEP
10/200 mg (white) and 25/200 mg (blue)
doravirine/TDF/3TC FDC (Delstrigo)
18 September 2019. Related: ARVs and PrEP, Fixed dose combinations, NNRTIs, Nukes
Delstrigo is a light yellow tablet embossed with “776” on one side. (Source: aidsinfo.nih)
Dovato (dolutegravir + lamivudine)
30 August 2024. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes
Dovato is a white tablet embossed with “SV137”. (Source: aidsinfo.nih)
emtricitabine (FTC)
12 April 2016. Related: ARVs and PrEP, Nukes
Eviplera (rilpivirine + tenofovir + FTC)
3 May 2013. Related: ARVs and PrEP, Fixed dose combinations, NNRTIs, Nukes
Generic ARVs
30 August 2024. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, NNRTIs, Nukes, PIs
A generic drug is one that is manufactured by a different pharmaceutical company to the company that invented the medicine.
Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)
12 April 2016. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes, PK booster
Full details about Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)
Kivexa (abacavir + 3TC)
2 January 2018. Related: ARVs and PrEP, Nukes
Lamivudine (3TC)
4 January 2022. Related: ARVs and PrEP, Nukes
Odefsey (rilpivirine + TAF + emtricitabine)
4 January 2022. Related: ARVs and PrEP, Fixed dose combinations, NNRTIs, Nukes
Full details about Odefsey (rilpivirine + TAF + emtricitabine)
Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)
4 January 2022. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes
Full details about Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)
Symtuza (darunavir + cobicistat + emtricitabine + TAF)
12 May 2018. Related: ARVs and PrEP, Fixed dose combinations, Nukes, PIs
Full details about Symtuza (darunavir + cobicistat + emtricitabine + TAF)
tenofovir alafenamide (TAF)
12 February 2018. Related: ARVs and PrEP, Nukes, PrEP
No picture: TAF is only available in coformulations with other HIV drugs.
tenofovir disoproxil (TD)
1 December 2020. Related: ARVs and PrEP, Nukes, PrEP
TLE (tenofovir DF/lamivudine/efavirenz)
2 February 2025. Related: ARVs and PrEP, Fixed dose combinations, NNRTIs, Nukes
Please see Atripla.
Triumeq (dolutegravir + abacavir + 3TC)
30 August 2024. Related: ARVs and PrEP, Fixed dose combinations, Integrase inhibitors, Nukes
Trizivir (AZT + 3TC + abacavir)
26 August 2012. Related: ARVs and PrEP, Fixed dose combinations, Nukes
Truvada (tenofovir-DF + FTC)
4 January 2022. Related: ARVs and PrEP, Nukes, PrEP
